Cannara Biotech, Inc. · TSX:LOVE
Cannara Biotech — Pitch Deck (April 2018)
24 slides from Cannara Biotech's pitch deck, April 2018
Slide 1: Cannara Biotech Investor Deck April 2018
Cannara Biotech plans to operate the largest indoor medical cannabis cultivation facility in Quebec. INVESTOR DECK April 2018
Slide 2: Disclaimer
2 DISCLAIMER Confidential Information This presentation and the information contained within is confidential, proprietary and for authorized use only. It is being presented to prospective investors solely for such investors’ confidential use, with the express understanding that, without the prior pe
Slide 3: The Market by the Numbers
THE MARKET BY THE NUMBERS They are calling the Canadian Cannabis Market the next (.com) boom $22.6 10/2018 94 BILLION DATE LICENSES Deloitte’s current estimates on Expected date for legalization Current number of Canadian the value of the Canadian of recreational cannabis use in licenses issued. Pro
Slide 4: Quebec has only 6 Licensed Producers
Quebec has only 6 Licensed Number of licenses issued by province Producers. • Quebec is the 2nd most populated and 2nd highest cannabis consuming province. • Societé du cannabis du Quebec anticipates a supply deficit. • Export demands are increasing along side domestic demand. Licensed Producers Rat
Slide 5: About Us
5 ABOUT US Cannara Biotech plans to operate the largest indoor medical cannabis cultivation facility in Quebec. The Company will offer a variety of organic cannabis infused medical products and flowers. Cannara Biotech intends to extract oil organically using a supercritical carbon dioxide extractor
Slide 6: Signed Partnership with FV Pharma
6 SIGNED PARTNERSHIP WITH FV PHARMA FV Pharma is a federally-licensed producer of medical cannabis under the Access to Cannabis for Medical Purposes Regulations (ACMPR), operating out of a 620,000-square-foot facility located in Cobourg, Ontario. • FV Pharma intends to operate a second production si
Slide 7: Cannara Biotech Facility
CANNARA BIOTECH FACILITY Quebec’s Largest Indoor medical cannabis production facility. FACILITY LOCATION ELECTRICAL SECURITY SIZE POWER • 625,000 square foot facility • Prime location 45 minutes • Over 8000 AMPS • A modern and secured • $50 million replacement from downtown Montreal • 3 independent
Slide 8: The Location
THE LOCATION Farnham Quebec is the ideal location for a large production facility. AVAILABLE WORKFORCE A STABLE POPULATION 1 in 3 people in Farnham are between the age of Canada Census – Farnham, Quebec Community Profile 18-50 making for a healthy available workforce. References 2011(4) 2006(5) earl
Slide 9: Optimal Indoor Facility
OPTIMAL INDOOR FACILITY Indoor cultivation is a key requirement for high grade medical cannabis. It allows for greater control over such elements as air temperature, humidity, water temperature, nutrient strength, pH balance, mold, mildew, and pest prevention among others. Sub-systems are set up in
Slide 10: Ideal Location City Access
10 IDEAL LOCATION CITY ACCESS 250 meters from Hydro Less than 1 hour drive from Quebec power station downtown Montreal
Slide 11: Industrial Space Loading Docks
INDUSTRIAL SPACE LOADING DOCKS Fully fenced-in and well-secured 15 loading docks, easy facility. Sprinkler system highway access throughout the facility.
Slide 12: Open Space Expansion
OPEN SPACE EXPANSION Extremely versatile layout with 31 foot ceilings allows for a 2 floor nd ingress, egress access. expansion, Potentially adding additional 350,000 square foot.
Slide 13: Security
13 SECURITY The campus was built as a secure industrial facility. SECURE FACILITY POLICE & FIRE UPGRADE The campus utilizes the natural • Police station is 5 km away The campus is easily barriers of its terrain combined with • Fire station is 4 km away upgraded to higher levels of an enclosed securi
Slide 14: Quebec Has the Lowest Electricity Costs in North America
QUEBEC HAS THE LOWEST ELECTRICITY COSTS IN NORTH AMERICA Electricity is the largest operating cost PROXIMITY CURRENT CAPACITY COST SAVING Main Hydro Quebec power station • 3 Independent power entries • This can equate to millions in is 250 meters from location savings per annum • 7200 AMPS @ 600 VOL
Slide 15: Joint Ventures with Israel in the Works
15 JOINT VENTURES WITH ISRAEL IN THE WORKS Israel is considered to be a global leader in medical cannabis research and innovation. Cannara Biotech CEO, Mr. Zohar Krivorot, was born in Israel and possesses a deep knowledge of the culture, as well as many strategic contacts, which he plans to leverage
Slide 16: Financing
16 FINANCING Please be advised that orders will be filled on a first come first served basis and the book may close without notice. SHARE PRICE CAPITAL STRUCTURE $0.10 CDN TOTAL OFFERING SIZE CLASS A $13,000,000 CDN Common Voting Shares 15,000 Issued and Outstanding DEBT $0 CLASS B ELIGIBILITY Commo
Slide 17: Use of Funds
17 USE OF FUNDS USE PURCHASE OF BUILDING BUILD-OUT OPERATING EXPENSES AMOUNT $13,000,000 B U I L D - O U T > Initial build-out is 25,000 square ft.
Slide 18: The Team
THE TEAM cannara’
Slide 19: Zohar Krivorot
ZOHAR KRIVOROT FOUNDER & CEO Zohar Krivorot is a successful entrepreneur. Zohar has founded, advised, invested and sold numerous companies, including Voice over IP application platform 911ENABLE™, which he led from start-up to its acquisition by West telecom in 2014. Zohar has been recognized as a t
Slide 20: Alexander Wolfe, Besar Xhelili
20 ALEXANDER WOLFE VP OF BUSINESS DEVELOPMENT An accomplished business leader with 10 years experience in management, sales and marketing. Record of success in developing campaigns, strategies, and solutions that have generated over 300% YOY revenue growth . A Skilled strategist and negotiator, reco
Slide 21: Dr. Michael Liverman, Etienne Ledoux
21 Dr. MICHAEL LIVERMAN CHIEF SCIENCE OFFICER C.S.O A medical professional with degrees from McGill University and with 40 years of expertise as a Dental Surgeon/Administrator managing a patient care clinic. Michael possesses excellent communication and people skills. He is a long time advocate of m
Slide 22: Wayne Karim, David Hyde
WAYNE KARIM 22 LEAD SCIENTIFIC COUNCIL Wayne J. M. Karim completed his studies for Bachelor’s of Science in Biology at the University of California Riverside, and his studies for Master’s of Science in Medicinal Chemistry at the University of San Francisco. Following his employment as Director of Ex
Slide 23: Larissa Feldman, Richard Sharp
LARISSA FELDMAN 23 ADVISOR Larissa Feldman is a pharmacist and co-owner of Feldman and Messias Pharmacy. She has been a long- time supporter and medical cannabis research advocate particularly for sleep, pain, anxiety, and oncology treatments. Larissa frequently contributes articles to industry publ
Slide 24: Investment and Business Inquiries
INVESTMENT INQUIRIES Anthony J. Durkacz Executive Vice President anthony@firstrepubliccapital.com 1 416-720-4360 BUSINESS INQUIRIES Alex Wolfe Cannara Biotech alex@cannara.ca www.cannara.ca 1 514-222-4237